Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2D | Q13557 | 4/20 | 0.50 |
| ▸ | PRKCB | P05771 | 4/20 | 0.47 |
| ▸ | PRKCA | P17252 | 4/20 | 0.47 |
| ▸ | PRKCH | P24723 | 4/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 4/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 4/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | CCR6 | P51684 | 1/20 | 0.43 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7785201 | 0.86 | CAMK2D (0.61) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL5686050 | 0.86 | CAMK2D (0.57) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL5686010 | 0.83 | CAMK2D (0.50) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL7782574 | 0.83 | CAMK2D (0.48) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL8316483 | 0.79 | CAMK2D (0.51) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL20243386 | 0.79 | CAMK2D (0.55) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL15797114 | 0.79 | PRKCB (0.54) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL5686034 | 0.78 | CAMK2D (0.48) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL22592333 | 0.78 | PDE9A (0.51) | CAMK2DPRKCBPRKCAPRKCHPRKCE | |
| SCHEMBL19217026 | 0.77 | CAMK2D (0.50) | CAMK2DPRKCBPRKCAPRKCHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140070-A1 | TREATMENT OF CONDITIONS WITH A NEED FOR THE INHIBITION OF GSK-3 | SMITHKLINE BEECHAM PLC (GB) | 2001-10-10 | — | — | EP | claimed |
| WO-2000038675-A1 | TREATMENT OF CONDITIONS WITH A NEED FOR THE INHIBITION OF GSK-3 | SMITHKLINE BEECHAM PLC (GB) | 2000-07-06 | — | — | WO | claimed |
| WO-2005028678-A9 | METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY | WYETH CORP (US) | 2006-08-31 | — | — | WO | disclosed |
| EP-1636388-A2 | METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY | Wyeth (US) | 2006-03-22 | — | — | EP | disclosed |
| WO-2005028678-A2 | METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY | WYETH (US) | 2005-03-31 | — | — | WO | disclosed |